← Back to all trials
Recruiting
NCT06315075
Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial
Conditions: Self-harm, Suicidal Ideation, Suicide and Self-harm
Sex: All
Ages: 13 Years – 18 Years
Healthy volunteers: No
Phase: NA
Enrollment: 140
Sponsor: Haukeland University Hospital
Location: Dept. of child and adolescent psychiatry, Haukeland University Hospital Bergen Bergen
Summary
The goal of this pre-post-follow-up study is to examine how well the treatment Dialectical behavior therapy for adolescents (DBT-A) with a duration of 20 weeks for adolescents with self-harm and suicidal behavior works in routine clinical practice. The main questions it aims to answer are:
* to investigate how well DBT-A works after treatment and at 3-month follow-up, measured by episodes of self-harm, suicide attempts, depressive symptoms and quality of life, drop-out from treatment and number of possible participants who decline DBT-A.
* to investigate how well DBT-A works at 12 months follow-up
* to investigate whether pre-treatment factors can predict who will benefit from treatment
Eligibility Criteria
Inclusion Criteria:
* Age 13-18 years
* Ongoing or a history of self-harm the last six months; current suicidal behavior (suicidal thoughts or at least one suicide attempt within the previous six months); at least three criteria of Diagnostic and Statistical Manual -5 (DSM-5) Borderline personality disorder (BPD), or the self-destruction criterion of DSM-5 BPD in addition to minimum two subthreshold criteria as assessed by the Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD) (First et al., 2016)
* Fluency in Norwegian
* One parent/trusted adult that can participate together with the adolescent.
Exclusion Criteria:
* Intellectual disability
* Significant learning or language impairments
* Autism spectrum disorder
* Anorexia Nervosa
* Any psychotic disorder
* Substance abuse disorder. These patients will be offered treatment as usual at their local outpatient clinic.
Source: ClinicalTrials.gov (NCT06315075). StuddyBuddy aggregates publicly available trial information.